“Women and people of diverse backgrounds remain underrepresented in the upper echelons of the biopharma C-suite,” says Ilona Gutcher, director of BD&L Oncology at Bayer. Aligning with International Women’s Day (Wednesday 8th March) the BioProcess Insider Expression Platform has released its second episode of Voices of Biotech. “I wouldn’t be here without the I&D Xcelerate program,” says Gutcher, another graduate of the Bayer program launched by Marianne De backer two years ago to promote diversity through a 6–9 month placement…

Deepa Talpade discusses how women can reach their full potential in life sciences through schemes like Bayer’s I&D Xcelerate program in the first episode of our Voices of Biotech podcast. Concurrent with International Day of Women and Girls in Science (Friday 10 February), the BioProcess Insider Expression Platform has launched Voices of Biotech – a podcast that celebrates women and minorities in science and what more can be done to amplify their voices. Despite the progress over the last decade,…

The latest edition of the BioProcess Insider Expression Platform has NIBRT’s Killian O’Driscoll speaking on Ireland’s robust biomanufacturing environment, training programs, and vendor-led technologies. Ireland has long established itself as a drug manufacturing hub and is home to commercial production sites run by Big Pharma firms including Pfizer, J&J, Eli Lilly, and AstraZeneca, as well as numerous third-party manufacturing organizations and bioprocess vendor firms. The country has evolved to mirror industry’s shift from small molecule to large molecule, and now…

With expertise in development and CMC in short supply globally, CDMO choice is absolutely critical for sponsors relying on them to accelerate development pathway, says Pharmatech Associates. Ahead of November’s CPhI Worldwide event in Frankfurt, Germany, BioProcess Insider hosted a LinkedIn Live discussion with Bikash Chatterjee and Stephanie Gaulding, the respective CEO and MD at drug development consultancy firm Pharmatech Associates about current outsourcing strategies and how to go about selecting a CDMO partner. Listen to the full discussion, as…

Training, virtual reality, and uptake in courses are all critical factors that need to be addressed to meet the demand for talent in the advanced therapy space, according to industry academics. This episode of the BioProcess Insider Expression Platform (BIEP) podcast brings you an in-depth conversation with Stuart Curbishley, head of business and project development, advanced therapies at University of Birmingham and Ivan Wall, CEO, Four-Plus and director of the National Training Center for advanced therapies manufacturing. We delve deep into…

Martin Meeson discusses Fujifilm Diosynth Biotechnologies’s role in pandemics past and future, and why the CDMO just won’t stop investing in capacity. The BioProcess Insider Expression Platform (BIEP) is back, bringing you some of the conversations you may have missed at BIO 2022 in San Diego, California. We sat down with Martin Meeson, CEO of Fujifilm Diosynth Biotechnologies, to discuss industry’s learnings from the pandemic. “[COVID-19] was a pandemic but I just worry we forget and we won’t use the…